cellular
• decreased migration and adhesion of nave T cells in response to chemokines CXCL12 and CCL21 and of activated T cells in response to CXCL12, CCL5, CXCL10 and CCL20 in vitro
• migration of donor T cells into spleen of wildtype hosts
• 24% decreased migration of donor T cells into lymph nodes of wildtype hosts
|
• decreased migration and adhesion of nave T cells in response to chemokines CXCL12 and CCL21 and of activated T cells in response to CXCL12, CCL5, CXCL10 and CCL20 in vitro
|
• decreased migration and adhesion of nave T cells in response to chemokines CXCL12 and CCL21 and of activated T cells in response to CXCL12, CCL5, CXCL10 and CCL20 in vitro
• 24% decreased migration of donor T cells into lymph nodes of wildtype hosts
• migration of donor T cells into spleen of wildtype hosts
|
hematopoietic system
• decreased migration and adhesion of nave T cells in response to chemokines CXCL12 and CCL21 and of activated T cells in response to CXCL12, CCL5, CXCL10 and CCL20 in vitro
|
• decreased migration and adhesion of nave T cells in response to chemokines CXCL12 and CCL21 and of activated T cells in response to CXCL12, CCL5, CXCL10 and CCL20 in vitro
• 24% decreased migration of donor T cells into lymph nodes of wildtype hosts
• migration of donor T cells into spleen of wildtype hosts
|
immune system
• decreased migration and adhesion of nave T cells in response to chemokines CXCL12 and CCL21 and of activated T cells in response to CXCL12, CCL5, CXCL10 and CCL20 in vitro
|
• decreased migration and adhesion of nave T cells in response to chemokines CXCL12 and CCL21 and of activated T cells in response to CXCL12, CCL5, CXCL10 and CCL20 in vitro
• 24% decreased migration of donor T cells into lymph nodes of wildtype hosts
• migration of donor T cells into spleen of wildtype hosts
|